An official website of the United States government
Global Health Matters May/June 2022
NIH requests input on greater equity in global health research
Fogarty and seven partner NIH institutes and centers request input on approaches NIH might take to promote greater equity in global health research conducted low- and middle- income countries. Submit comments by August 1, 2022.
Fogarty awards $29M to U.S. university consortia in revamp of Fellows and Scholars program
Fogarty renewed our flagship Global Health Fellows and Scholars program. LAUNCH, or "Launching Future Leaders in Global Health Research Training Program," fosters the next generation of global health scientists.
Opinion: To improve global health, we need to invest in people
WHO estimates an additional 18 million health workers are needed globally by 2030. Since 1989, Fogarty has trained more than 7,500 individuals from over 130 countries as part of our mission to build research capacity in low- and middle-income countries.
Failing less by listening more: How to create sustainable teen HIV care
At the annual meeting of the Adolescent HIV Prevention and Treatment Implementation Science Alliance Drs. Linda-Gail Bekker and Elvin Geng spoke about tailoring HIV interventions to the needs of adolescent populations and considering the context of those interventions.
Profile: Former Fogarty fellow Siana Nkya tackles sickle cell disease in Tanzania
Seeing the impact sickle cell disease had on many Tanzanians, former Fogarty Fellow Dr. Siana Nkya chose to research the genetic factors that influence fetal hemoglobin levels and the correlation with severity of the disease.
Reducing injuries in Egypt: Q & A with Mohamed Seif El-din
Mohamed Seif El-din credits his Fogarty training with developing his appetite for acquiring knowledge in fields parallel to his own. His current role in the ministry of health includes managing the central administration of all urgent and critical care.
Focus: Reckoning with the global toll of antimicrobial resistance
Resistant pathogens end more lives than HIV/AIDS and malaria. No nation is immune to AMR, yet it is low- and middle-income countries, home to nearly 85% of the world’s population, that shoulder the highest burden.
Also In This Issue
Print this Issue
Download and print:
Note: While the PDF version of this issue is not 508 compliant, the web versions of all articles are compliant.
Subscribe
Subscribe to Fogarty's Global Health Matters newsletter.
To view Adobe PDF files, download current, free accessible plug-ins from Adobe's website .